Current Research in Head and Neck Cancer: Molecular Pathways, Novel Therapeutic Targets, and Prognostic Factors.RF16 2004-020575 3-8055-7789-3 Current research in head and neck cancer; molecular pathways, novel therapeutic targets, and prognostic factors. Title main entry. Ed. by Henning Bier bier n. 1. A stand on which a corpse or a coffin containing a corpse is placed before burial. 2. A coffin along with its stand: followed the bier to the cemetery. . (Advances in oto-rhinolaryngology; v.62) S. Karger, AG, [c]2005 207 p. $180.00 Bier (otorhinolaryngology otorhinolaryngology /oto·rhi·no·lar·yn·gol·o·gy/ (-ri?no-lar?ing-gol´ah-je) the branch of medicine dealing with the ear, nose, and throat. o·to·rhi·no·lar·yn·gol·o·gy n. , Heinrich Heine U., Germany) presents 16 articles detailing recent work on understanding various aspects of head and neck cancer. The research papers discuss such topics as hypofolatemia as a risk factor, reduced DNA repair capacity in laryngeal cancer subjects, antiangiogenic therapy of head and neck squamous cell carcinoma squamous cell carcinoma n. A carcinoma that arises from squamous epithelium and is the most common form of skin cancer. Also called cancroid, epidermoid carcinoma. by vascular endothelial growth factor Vascular endothelial growth factor (VEGF) is an important signaling protein involved in both vasculogenesis (the de novo formation of the embryonic circulatory system) and angiogenesis (the growth of blood vessels from pre-existing vasculature). antisense therapy, p53-based immunotherapy of cancer, and imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion